Biotech entity
All 1 tracked stories fall under one category: acquisition. Biolife Solutions Inc. is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each carries 2 original sources on average. We currently track 1 Biotech story that mention Repligen Corp., all published on June 27, 2026.
Last mentioned: Jun 27, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: acquisition. Biolife Solutions Inc. is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each carries 2 original sources on average. We currently track 1 Biotech story that mention Repligen Corp., all published on June 27, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 1 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Repligen Corp.. Shared-story counts are live from our verified record — not editorial picks.
Repligen’s reported interest in Biolife Solutions could create a bioprocessing-to-cryopreservation powerhouse. For the biotech industry, this deal promises an integrated supplier but raises concerns about supplier consolidation as the cell and gene therapy market expands at over 20% CAGR.
Source: Bloomberg · Seeking Alpha
Repligen Corp. is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
